Terns Pharmaceuticals, Inc.

    TERN ·NASDAQ ·Pharmaceutical Preparations ·Inc. in DE
    Loading chart...
    Track markets on TradingView

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals. Values reported in .

    showing loading…

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Next expected filings

    • ~2026-11-09 10-Q expected by 2026-11-09 (in 76 days)
    • ~2027-04-05 10-K expected by 2027-04-13 (in 223 days)
    • ~2027-05-07 10-Q expected by 2027-05-07 (in 255 days)
    • ~2027-08-04 10-Q expected by 2027-08-04 (in 344 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-05-05 8-K Completion of Acquisition/Disposition; Delisting Notice; Material Modification to Rights; Control Change; Officer/Director Change; Bylaws/Articles Amended; Other Events; Financial Statements and Exhibits
    • 2026-04-27 8-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
    • 2026-04-27 10-K/A Annual Report (Amended)
    • 2026-03-30 10-K Annual Report
    • 2026-03-25 8-K Material Agreement Entered; Regulation FD Disclosure; Financial Statements and Exhibits
    • 2026-01-22 8-K Material Agreement Entered
    • 2026-01-09 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-12-11 8-K Other Events; Financial Statements and Exhibits
    • 2025-12-08 8-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
    • 2025-11-10 10-Q Quarterly Report
    • 2025-11-10 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-11-03 8-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
    • 2025-10-22 8-K Other Events; Financial Statements and Exhibits
    • 2025-08-05 10-Q Quarterly Report
    • 2025-08-05 8-K Earnings Release; Financial Statements and Exhibits